These findings suggest a relationship between ALDH3A1 and tumor immunity, thereby indicating the potential translational relevance of cell-intrinsic ALDH3A1 expression/activity in response to PD-1/PD-L1 blockade treatment. The gene discussed is CD274; the disease is neoplasm.